Treace Medical Concepts Inc (TMCI)
7.83
-0.11
(-1.39%)
USD |
NASDAQ |
Nov 22, 16:00
7.83
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts Cash from Financing (Quarterly): 0.008M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.008M |
| June 30, 2024 | 0.311M |
| March 31, 2024 | -0.185M |
| December 31, 2023 | 0.165M |
| September 30, 2023 | 0.159M |
| June 30, 2023 | 1.18M |
| March 31, 2023 | 107.88M |
| December 31, 2022 | 0.297M |
| September 30, 2022 | 0.353M |
| June 30, 2022 | 18.78M |
| Date | Value |
|---|---|
| March 31, 2022 | 1.372M |
| December 31, 2021 | 1.026M |
| September 30, 2021 | 0.041M |
| June 30, 2021 | 107.80M |
| March 31, 2021 | -1.219M |
| December 31, 2020 | 0.323M |
| September 30, 2020 | 9.351M |
| June 30, 2020 | 1.796M |
| March 31, 2020 | 0.033M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.219M
Minimum
Mar 2021
107.88M
Maximum
Mar 2023
13.13M
Average
0.323M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Stryker Corp | 2.653B |
| Perspective Therapeutics Inc | 0.628M |
| Retractable Technologies Inc | -0.1343M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.84M |
| Cash from Investing (Quarterly) | 5.763M |
| Free Cash Flow | -43.20M |
| Free Cash Flow Per Share (Quarterly) | -0.2363 |
| Free Cash Flow to Equity (Quarterly) | -14.78M |
| Free Cash Flow Yield | -8.90% |